This week, Pharmacy Choice published an announcement that patient enrollment has begun in the RECITAL (A Patient Registry Evaluating Closure Following Access with the Arstasis One Access System) Study. The non-randomized, prospective, post-approval study anticipates enrolling up to 500 patients in at least seven U.S. hospitals including Cooper.